scholarly article | Q13442814 |
P50 | author | Nancy Andrews | Q4793337 |
Mark D Fleming | Q57330225 | ||
P2093 | author name string | Thomas B Bartnikas | |
P2860 | cites work | Regulation of transferrin receptor 2 protein levels by transferrin | Q24301632 |
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease | Q28209487 | ||
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver | Q28506594 | ||
Lack of the bone morphogenetic protein BMP6 induces massive iron overload | Q28510138 | ||
Iron Loading and Overloading due to Ineffective Erythropoiesis | Q33844026 | ||
The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo | Q33883160 | ||
Regulators of iron balance in humans | Q34060240 | ||
Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis | Q34625175 | ||
Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression | Q34658174 | ||
Suppression of hepcidin during anemia requires erythropoietic activity | Q35848905 | ||
Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. | Q35990728 | ||
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression | Q36539421 | ||
Transferrin-a modulates hepcidin expression in zebrafish embryos | Q37142191 | ||
Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes | Q37207754 | ||
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells | Q37262477 | ||
The regulation of hepcidin and its effects on systemic and cellular iron metabolism. | Q37346708 | ||
Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis | Q37376502 | ||
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism | Q41871982 | ||
Transferrin therapy ameliorates disease in beta-thalassemic mice. | Q50586962 | ||
BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. | Q54472480 | ||
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia | Q56490107 | ||
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin | Q56490134 | ||
Iron absorption in hypotransferrinemic mice | Q67760881 | ||
Importance of anemia and transferrin levels in the regulation of intestinal iron absorption in hypotransferrinemic mice | Q73168671 | ||
The molecular defect in hypotransferrinemic mice | Q74055142 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 630-637 | |
P577 | publication date | 2010-10-18 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice | |
P478 | volume | 117 |
Q35105827 | A 3-marker index improves the identification of iron disorders in CKD anaemia. |
Q61451281 | A computational model to understand mouse iron physiology and disease |
Q47818911 | Addition of oral iron to plasma transfusion in human congenital hypotransferrinemia: A 10-year observational follow-up with the effects on hematological parameters and growth. |
Q41230516 | BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice. |
Q37472856 | Bmp6 expression can be regulated independently of liver iron in mice |
Q38226333 | Bone morphogenetic proteins as regulators of iron metabolism |
Q58793890 | Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis |
Q44320542 | Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing |
Q37928941 | Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice |
Q35640004 | Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection |
Q34783878 | Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice |
Q36631562 | Evidence that the expression of transferrin receptor 1 on erythroid marrow cells mediates hepcidin suppression in the liver |
Q55332155 | Excessive Iron Availability Caused by Disorders of Interleukin-10 and Interleukin-22 Contributes to High Altitude Polycythemia. |
Q58580509 | Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess |
Q28590419 | Hemojuvelin is essential for transferrin-dependent and transferrin-independent hepcidin expression in mice |
Q27002595 | Hepcidin and iron homeostasis |
Q27690828 | Hepcidin and iron regulation, 10 years later |
Q50918424 | Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8. |
Q38051401 | How I manage patients with atypical microcytic anaemia |
Q36892568 | Identification and characterization of a novel murine allele of Tmprss6. |
Q34658504 | Increased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway |
Q42573907 | Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis |
Q33992191 | Investigating the role of transferrin in the distribution of iron, manganese, copper, and zinc |
Q37822300 | Iron and erythropoiesis: a dual relationship |
Q37341829 | Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation |
Q64130325 | Iron metabolism and its association with dyslipidemia risk in children and adolescents: a cross-sectional study |
Q36677136 | Known and potential roles of transferrin in iron biology |
Q27009565 | Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances |
Q34700903 | Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose |
Q43175182 | Rapid elevation of transferrin saturation and serum hepcidin concentration in hemodialysis patients after intravenous iron infusion |
Q38214914 | Regulation of cellular iron metabolism and its implications in lung cancer progression |
Q50872606 | Relationship between hepcidin and ferritin in haemodialysed patients. |
Q36049503 | Suppressed hepcidin expression correlates with hypotransferrinemia in copper-deficient rat pups but not dams |
Q54358417 | The action of JAK, SMAD and ERK signal pathways on hepcidin suppression by polysaccharides from Angelica sinensis in rats with iron deficiency anemia. |
Q38830409 | The mutual control of iron and erythropoiesis. |
Q33825492 | The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease |
Q38196802 | The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body |
Q24339599 | The transcription factor ATOH8 is regulated by erythropoietic activity and regulates HAMP transcription and cellular pSMAD1,5,8 levels |
Q27021720 | The use of hypotransferrinemic mice in studies of iron biology |
Q33978886 | Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia |
Q37621602 | Zebrafish in the sea of mineral (iron, zinc, and copper) metabolism. |
Q35485724 | β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism |